Alternatives to Upstream Bio

AI-driven digital twin of embryo development for cell-based therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Compressing biology to develop the next generation of therapies.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Developing polymer-based nanoparticles for targeted gene therapy delivery.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing novel nitroxide-based therapeutics to treat inflammatory lung diseases.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Developing novel therapeutic approaches for ocular diseases.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Life sciences data platform for deep-phenotype multi-omics datasets.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Unleashing the power of genomics at scale for biological advances and human health.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

EU-based company providing personalized medicine solutions for medical practitioners.

Biotech company developing a novel drug delivery platform using cell membrane-derived nanoparticles.

Developing novel therapeutics for rare genetic diseases.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

VI Therapeutics is developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered platform for life sciences drug discovery and development.